I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| smooth muscle cell | 8 studies | 21% ± 4% | |
| pericyte | 6 studies | 25% ± 14% | |
| fibroblast | 6 studies | 25% ± 9% | |
| CD16-positive, CD56-dim natural killer cell, human | 4 studies | 20% ± 4% | |
| classical monocyte | 4 studies | 23% ± 5% | |
| myofibroblast cell | 4 studies | 26% ± 16% | |
| endothelial cell | 4 studies | 29% ± 4% | |
| natural killer cell | 3 studies | 21% ± 4% | |
| conventional dendritic cell | 3 studies | 24% ± 6% | |
| non-classical monocyte | 3 studies | 35% ± 11% | |
| epithelial cell | 3 studies | 38% ± 8% | |
| dendritic cell | 3 studies | 40% ± 15% | |
| endothelial cell of vascular tree | 3 studies | 21% ± 7% | |
| basal cell | 3 studies | 27% ± 8% | |
| connective tissue cell | 3 studies | 20% ± 3% |
